TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT00734825

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Omnipaque
Description: oral contrast for CT scan

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Omnipaque
Description: oral contrast for CT scan
Study: NCT04037488

Intervention type: DIAGNOSTIC_TEST
Intervention: Inbody 320
Description: Total Skeletal muscle mass (SMM), Skeletal muscle index (SMI), Relative Skeletal muscle mass index (RASM), Fat body mass (FBM), Body mass index (BMI), Body fat percentage, Body water content, Edema Value were calculated by Inbody 320
Study: NCT01216254

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: classic v high-frequency electrocoagulation
Description: During the BCT with SLND the investigators would use two types of electrocoagulation. The steps of the operation would remain the same in both arms, nevertheless the tool used would vary.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: classic v high-frequency electrocoagulation
Description: During the BCT with SLND the investigators would use two types of electrocoagulation. The steps of the operation would remain the same in both arms, nevertheless the tool used would vary.
Study: NCT02766257

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Anesthesia for ambulatory paediatric surgery
Study: NCT00239005

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enteric-Coated Mycophenolate Sodium (EC-MPS)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mycophenolate Mofetil (MMF)
Study: NCT01095887

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eculizumab
Description: Subjects received eculizumab intravenously at the time of transplant, on the day after transplant, then weekly for four weeks. At four weeks post transplant, anti-blood group antibody levels were determined. Subjects may have potentially received eculizumab every two weeks for one year depending on antibody levels.
Study: NCT00292227

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rotigotine
Description: Rotigotine patch applied once daily for a 24-hour period.~Rotigotine dose schedule (patch application days):~Day 1 through Day 7: 9.0 mg/day; Day 8 through Day 14: 18.0 mg/day; Day 15 through Day 21: 27.0 mg/day; Day 22 through Day 28: 36.0 mg/day; Day 29 through Day 35: 45.0 mg/day; Day 36 through Day 42: 54.0 mg/day; Day 43 through Day 44: 45.0 mg/day; Day 45 through Day 46: 36.0 mg/day; Day 47 through Day 48: 27.0 mg/day; Day 49 through Day 50: 18.0 mg/day; Day 51 through Day 52: 9.0 mg/day;

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo patch applied once daily for a 24-hour period. Size and number of patches matching to rotigotine dose schedule (patch application days):~Day 1 through Day 7: 9.0 mg/day; Day 8 through Day 14: 18.0 mg/day; Day 15 through Day 21: 27.0 mg/day; Day 22 through Day 28: 36.0 mg/day; Day 29 through Day 35: 45.0 mg/day; Day 36 through Day 42: 54.0 mg/day; Day 43 through Day 44: 45.0 mg/day; Day 45 through Day 46: 36.0 mg/day; Day 47 through Day 48: 27.0 mg/day; Day 49 through Day 50: 18.0 mg/day; Day 51 through Day 52: 9.0 mg/day;

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Moxifloxacin infusion
Description: Moxifloxacin 400 mg/250 mL iv solution infused over 1h once either on Day 32 or on Day 39

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo infusion
Description: Placebo saline solution 250 mL infused over 1h once either on Day 32 or on Day 39

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo infusion
Description: Placebo saline solution 250 mL infused over 1h once on both Day 32 and on Day 39
Study: NCT02179775

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propranolol

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Quince's oxymel

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study: NCT00470158

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: iron and zinc combined
Description: Children \>= 12 months received an average of 5mg zinc/day, 6.25 Iron/day, and 25IU folic acid/day. children\<12 received half that dose. This dose was alternated daily with placebo. Dissolvable doses were distributed in blister packs and reconstituted with a teaspoon of water. Doses were administered in the morning. For missed doses, the mother gave the child the next morning dose, and a second dose in the evening.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: iron and zinc on separate days
Description: Children \>= 12 months received an average of 5mg zinc/day, alternating daily with 6.25 Iron/day, and 25IU folic acid/day. Children\<12 received half that dose. Dissolvable doses were distributed in blister packs and reconstituted with a teaspoon of water. Doses were administered in the morning. For missed doses, the mother gave the child the next morning dose, and a second dose in the evening.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: iron
Description: Children \>= 12 months received an average 6.25 Iron/day, and 25IU folic acid/day. Children\<12 received half that dose. This dose was alternated daily with placebo. Dissolvable doses were distributed in blister packs and reconstituted with a teaspoon of water. Doses were administered in the morning. For missed doses, the mother gave the child the next morning dose, and a second dose in the evening.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Zinc
Description: Children \>= 12 months received an average of 5mg zinc/day. Children\<12 received half that dose. This dose was alternated daily with placebo. Dissolvable doses were distributed in blister packs and reconstituted with a teaspoon of water. Doses were administered in the morning. For missed doses, the mother gave the child the next morning dose, and a second dose in the evening.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Children received daily placebo. Dissolvable doses were distributed in blister packs and reconstituted with a teaspoon of water. Doses were administered in the morning. For missed doses, the mother gave the child the next morning dose, and a second dose in the evening.
Study: NCT03256188

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active classroom
Description: 30 minutes of moderate-to-vigorous physical activity
Study: NCT02477267

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SL spray

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SL spray

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SL film

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SL film
Study: NCT02133521

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DLBS1033
Description: Investigational drug or placebo will be given in addition to the standard therapy, consists of: aspirin enteric-coated tablet 1 x 80 mg daily, simvastatin film-coated tablet 1 x 20 mg daily, and vitamin B complex 1 x 1 tablet

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Investigational drug or placebo will be given in addition to the standard therapy, consists of: aspirin enteric-coated tablet 1 x 80 mg daily, simvastatin film-coated tablet 1 x 20 mg daily, and vitamin B complex 1 x 1 tablet
Study: NCT01711879

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aflibercept
Description: Details covered in arm description
Study: NCT03764657

Intervention type: PROCEDURE
Intervention: In hot group 16 patients were treated by diathermy in Cold
Description: In all interventions, the patients were placed in prone position on operating table with the gluteal line opened wide by adhesive patches; after skin disinfection, dimension and extension of cystic disease was studied by injection of hydrogen peroxide through superficial skin orifice. The same procedure was performed: an elliptical incision on midline around the sinus was made and the sinus was excided laterally and in depth on healthy tissue, down till the pre-sacral fascia: this common approach was made both using scalpel and electrosurgery in the two groups. During dissection and excision, in each group were measured and recorded the temperatures developing, both on the section surface using an infrared thermometer and thermal imaging camera, and deeper until 1 cm from the section frontline using a immersion thermometer sealed by a steri-drape to guarantee the sterility on surgical field. In this group excision was carried out with diatermocoagulation

Intervention type: PROCEDURE
Intervention: In hot group 16 patients were treated by diathermy in Cold
Description: In all interventions, the patients were placed in prone position on operating table with the gluteal line opened wide by adhesive patches; after skin disinfection, dimension and extension of cystic disease was studied by injection of hydrogen peroxide through superficial skin orifice. The same procedure was performed: an elliptical incision on midline around the sinus was made and the sinus was excided laterally and in depth on healthy tissue, down till the pre-sacral fascia: this common approach was made both using scalpel and electrosurgery in the two groups. During dissection and excision, in each group were measured and recorded the temperatures developing, both on the section surface using an infrared thermometer and thermal imaging camera, and deeper until 1 cm from the section frontline using a immersion thermometer sealed by a steri-drape to guarantee the sterility on surgical field. In this group excision was carried out with diatermocoagulation

Intervention type: PROCEDURE
Intervention: in Cold group 13 patients were treated by scalpel.
Description: the position and preparation of the patient on the operating table were the same as in the hot group, while the excision procedure performed with knife
Study: NCT03937271

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine pattern
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine pattern.

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine pattern
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine pattern.

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine pattern
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine pattern.

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine pattern
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine pattern.

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine tongue diagnosis
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine tongue diagnosis.
Study: NCT03764657

Intervention type: PROCEDURE
Intervention: in Cold group 13 patients were treated by scalpel.
Description: the position and preparation of the patient on the operating table were the same as in the hot group, while the excision procedure performed with knife
Study: NCT04516096

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMX0035
Description: Tauroursodeoxycholic Acid and Sodium Phenylbutyrate orally given twice a day
Study: NCT03937271

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine tongue diagnosis
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine tongue diagnosis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine tongue diagnosis
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine tongue diagnosis.
Study: NCT01711879

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aflibercept
Description: Details covered in arm description
Study: NCT03486717

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality goggles
Description: Patients will act as their own control over two different dental appointments. One appointment will consist of wearing the virtual reality googles, the other appointment will be conducted without them. The goggles have a small screen inside of them along with headphones. This device will play an a movie or cartoon that will immerse the patient during treatment.
Study: NCT03505671

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture Therapy
Description: Undergo acupuncture therapy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive usual care
Study: NCT03505671

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study: NCT03937271

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine tongue diagnosis
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine tongue diagnosis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine pulse diagnosis
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine pulse diagnosis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine pulse diagnosis
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine pulse diagnosis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine pulse diagnosis
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine pulse diagnosis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine pulse diagnosis
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine pulse diagnosis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine pulse diagnosis
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine pulse diagnosis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Traditional Chinese Medicine pulse diagnosis
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Traditional Chinese Medicine pulse diagnosis.

Intervention type: DIAGNOSTIC_TEST
Intervention: Heart rate variability
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Heart rate variability.
Study: NCT04543253

Intervention type: OTHER
Intervention: MUSE biofeedback
Description: biofeedback through a headband
Study: NCT01697527

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: aldesleukin
Description: Given SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fludarabine phosphate
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study: NCT03937271

Intervention type: DIAGNOSTIC_TEST
Intervention: Heart rate variability
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Heart rate variability.

Intervention type: DIAGNOSTIC_TEST
Intervention: Heart rate variability
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Heart rate variability.

Intervention type: DIAGNOSTIC_TEST
Intervention: Heart rate variability
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Heart rate variability.

Intervention type: DIAGNOSTIC_TEST
Intervention: Heart rate variability
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Heart rate variability.

Intervention type: DIAGNOSTIC_TEST
Intervention: Heart rate variability
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Heart rate variability.

Intervention type: DIAGNOSTIC_TEST
Intervention: Schirmer's test
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Schirmer's test.

Intervention type: DIAGNOSTIC_TEST
Intervention: Schirmer's test
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Schirmer's test.

Intervention type: DIAGNOSTIC_TEST
Intervention: Schirmer's test
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Schirmer's test.

Intervention type: DIAGNOSTIC_TEST
Intervention: Schirmer's test
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Schirmer's test.
Study: NCT01697527

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NY-ESO-1 reactive TCR retroviral vector transduced autologous PBL
Description: Undergo NY-ESO-1 reactive TCR retroviral vector transduced autologous PBL

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: dendritic cell vaccine therapy
Description: Given NY-ESO-1-157-165 peptide pulsed dendritic cell vaccine ID

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: fludeoxyglucose F 18
Description: Undergo PET scan using \[18F\] FDG tracer

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: positron emission tomography
Description: Undergo fludeoxyglucose F18 PET
Study: NCT03937271

Intervention type: DIAGNOSTIC_TEST
Intervention: Schirmer's test
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Schirmer's test.

Intervention type: DIAGNOSTIC_TEST
Intervention: Schirmer's test
Description: Autoimmune disease (AID) as Sjögren's syndrome (SJS), Systemic lupus erythematosus (SLE), Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Ankylosing spondylitis (AS) for comparing with the Dry eye syndrome (DES) subjects will take the Schirmer's test.
Study: NCT00895479

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Graft placement surgery plus Trinam therapy
Description: Trinam arm: graft placement surgery plus 1ml perivascular administration of Trinam vector.~Control arm: graft placement surgery
Study: NCT03864731

Intervention type: DEVICE
Group type: OTHER
Intervention: Bone conduction device (ADHEAR)
Description: adhesive bone conduction device
Study: NCT04145336

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 5cm 5-Fr PDS
Description: High-risk patients receive 5cm 5-Fr PDS

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 7cm 5-Fr PDS
Description: High-risk patients receive 7cm 5-Fr PDS

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Indomethacin
Description: All patients without contraindications should be administrated with rectal indomethacin within 30 min before ERCP.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indomethacin
Description: All patients without contraindications should be administrated with rectal indomethacin within 30 min before ERCP.